Description
CJC-1295 + Ipamorelin puts the best-known pairing in growth-hormone axis research into a single vial: a GHRH analogue and a selective ghrelin-receptor agonist, lyophilized together at a fixed 1:1 ratio. Pure Peptides Canada supplies it in 5 mg + 5 mg and 10 mg + 10 mg vials, with an independent Janoshik lab report, CAD pricing and tracked shipping from inside Canada.
CJC-1295 + Ipamorelin at a glance
- What it is: two growth-hormone secretagogues blended 1:1. CJC-1295 acts on the GHRH receptor and ipamorelin acts on the ghrelin receptor (GHS-R1a).
- Why researchers pair them: the two receptors are separate pathways, so the combination is used to study complementary GHRH and ghrelin-receptor signalling.
- Why buy it blended: the ratio is fixed when the vial is made, so you avoid combining two vials at the bench.
- Supplied as: sealed lyophilized powder, 5 mg + 5 mg or 10 mg + 10 mg, single vial or box of 10.
- Delivery: ships from inside Canada by tracked Xpresspost in 3–7 days ($25 CAD), or free in 4–12 days on orders over $299.
CJC-1295
- Class: GHRH analogue, a modified GHRH(1-29)
- Receptor: GHRH receptor on pituitary somatotrophs
- Design: four amino-acid substitutions that slow enzymatic breakdown
- Sold alone as CJC-1295 No DAC and CJC-1295 with DAC
Ipamorelin
- Class: growth-hormone secretagogue (GHRP family)
- Receptor: ghrelin receptor, GHS-R1a
- Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2, 711.9 g/mol
- Sold alone as Ipamorelin 10 mg
Why CJC-1295 and ipamorelin are studied together
Growth-hormone release from the pituitary is controlled by two stimulatory inputs. Growth-hormone-releasing hormone (GHRH) acts through its own receptor, while ghrelin and the synthetic GHRPs act through GHS-R1a. Researchers have known since the 1990s that stimulating both pathways at once produces a different response from either alone, so pairing a GHRH analogue with a ghrelin-receptor agonist is a common design in secretagogue research.
Ipamorelin is the usual choice on the ghrelin side because, in the original animal work, it did not raise ACTH or cortisol the way older GHRPs did. CJC-1295 is a stabilized GHRH analogue with a longer working life than native GHRH. All of this comes from cell, animal and early human pharmacology studies. Neither compound is an approved medicine.
Regulatory status: neither CJC-1295 nor ipamorelin is an authorized drug in Canada, and Health Canada’s April 2026 public advisory on unauthorized injectable peptides names both. Growth-hormone secretagogues are also on the World Anti-Doping Agency prohibited list. We sell this blend strictly as a laboratory reagent for in-vitro research.
Why researchers order this blend from Pure Peptides Canada
Choose 5 + 5 mg or 10 + 10 mg above. Orders over $299 ship free across Canada.
See lab resultsWhich size should I choose?
| Option | Contents | Best for |
|---|---|---|
| 5 mg + 5 mg | 10 mg peptide total | Pilot work and shorter studies |
| 10 mg + 10 mg | 20 mg peptide total | Longer studies with fewer vials to prepare |
| Box of 10 (either size) | 10 sealed vials | Multi-arm designs and labs that reorder, at the lowest per-vial price |
CJC-1295 + Ipamorelin FAQ
Where can I buy CJC-1295 with ipamorelin in Canada?
Pure Peptides Canada stocks CJC-1295 + ipamorelin as a pre-blended lyophilized research reagent in 5 mg + 5 mg and 10 mg + 10 mg vials, shipped from inside Canada by tracked Xpresspost in 3–7 days ($25 CAD), or free in 4–12 days on orders over $299.
Why buy the blend instead of two separate vials?
The ratio is set during lyophilization, so you skip combining two separately prepared vials and the small measurement errors that come with it. You also prepare and store one vial instead of two. If you need to vary the ratio, buy CJC-1295 and ipamorelin separately.
What does 5 mg + 5 mg mean?
Each vial contains 5 mg of CJC-1295 and 5 mg of ipamorelin, 10 mg of peptide in total. The 10 mg + 10 mg vial doubles both.
Is this blend third-party tested?
Yes. Janoshik Analytical, an independent lab, tests by HPLC for purity and mass spectrometry for identity. Our COA guide explains how to read a report.
Is CJC-1295 with ipamorelin approved by Health Canada?
No. Neither peptide is an authorized drug in Canada, and Health Canada’s April 2026 advisory names both among unauthorized injectable peptides. This blend is sold only as a laboratory reagent for in-vitro research.
Can this blend be used in people or animals?
No. It is for in-vitro laboratory research only and is not a drug, supplement or food. We do not provide dosing or administration information.
For laboratory research use only. Not a drug, supplement, food or cosmetic, not for human or veterinary use, and not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.